Press release
The Clostridium Difficile Infection Treatment Market to Get Digitally Distilled
The critical need for non-antibiotic alternatives for prophylaxis and treatment of Clostridium difficile infections is shaping the market landscape of Clostridium difficile infection treatment. The global clostridium difficile infection treatment market was valued US$ 840 Mn in 2018 and will exhibit a promising CAGR during the forecast period (2019 - 2029). Key factors such as easy accessibility of diagnostic tests and accessibility of generic antimicrobial drugs (metronidazole and Vancomycin) continue to fuel the Clostridium difficile infection treatment market growth.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/15775
Increasing incidence of Clostridium difficile infection demands for strengthening R&D program, thereby propelling growth of the Clostridium difficile infection treatment market. In 2017, Actelion conducted phase III clinical trial for comparing cadazolid with vancomycin for the treatment of Clostridium difficile associated diarrhea. As per Center for Disease Control & Prevention (CDC) 2015, prevalence of C. difficile infection is increasing and is most common healthcare-associated infection among adults.
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Company Profiles:
Merck & Co., Inc
Baxter International Inc.
Sanofi S.A.
Pfizer Inc.
Novartis AG
Astellas Pharma
Eli LilIy & Company
AstraZeneca
Actelion Pharmaceuticals Ltd (Sub. of Johnson & Johnson Services, Inc.)
Mylan N.V.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/15775
Key Takeaways - Clostridium difficile Infection Treatment Market Study
Clostridium difficile infection treatment market is characterized as mature market. Whereas, introduction of new class of therapeutic agents (such as monoclonal antibodies) for treatment is expected to generate market growth opportunities.
Metronidazole, Fidaxomicin, and Vancomycin are most commonly prescribed medication. Although, prescription pattern is diverse across the world attributing to variation in the occurrence of Clostridium difficile infection after treatment with each class of drug.
In the U.S., metronidazole is suggested as a first line drug for Clostridium difficile treatment followed by the combination of vancomycin and fidaxomicin. In Western nations such as the U.S., Canada, and few European nations, utilization of anti-infection agents has flooded for over two decades, thus increasing the incidence of Clostridium difficile infection in these regions.
The sale of fidaxomicin, vancomycin, and metronidazole through retail pharmacies and mail order pharmacies is increasingly contributing to the global Clostridium difficile treatment market growth.
Uncontrolled utilization of broad range anti-infection drugs and absence of consistent cleanliness standards at clinics are increasing the rate of prevalence of Clostridium difficile infection.
Launch of monoclonal antibody drugs for treatment of Clostridium difficile infection and counteractive action for recurrent Clostridium difficile infection has shifted the focus from antibiotics to recently approved therapeutic class of drugs. This new class of drugs represents a breakthrough and will create an extreme challenge for conventional antibiotic medicines for Clostridium difficile infection.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/15775
Strategic Partnerships - Winning Imperatives for Market Leaders
The key players are focusing on new product launches, collaborations, territorial expansion, mergers, and acquisitions to increase share in the market. Mergers and acquisitions are helping these players to enhance existing product portfolio and topographical reach. For example, to fortify their pharmaceutical business, Johnson & Johnson acquired Actelion Ltd, enhancing the product portfolio for Clostridium difficile infection treatment.
To increase the market revenue, Astellas Pharma Inc. launched Dafclir Tablets 200 mg for the treatment of infectious enteritis (susceptible strains: fidaxomicin susceptible Clostridium difficile (CD)2) in Japan. To strengthen its product portfolio, USFDA granted acceptance for review of New Drug Application for DIFICID (fidaxomicin) for oral suspension in pediatric patients.
More Valuable Insights on Clostridium difficile Infection Treatment Market
Persistence Market Research offers a unique perspective and actionable insights on Clostridium difficile Infection treatment in its latest study, presenting historical demand assessment from 2014 - 2018 and projections from 2019 - 2029. The global Clostridium difficile infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on Clostridium difficile infection treatment market on basis of drug type (Metronidazole, Vancomycin, Fidaxomicin), route of administration (oral, injectable) and distribution channel (hospital pharmacies, retail pharmacies, mail order pharmacies) across five major regions.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/clostridium-difficile-infection-treatment-market.asp
Read More Trending "PMR Exclusive Article"-
Biobetters Market@ https://www.persistencemarketresearch.com/market-research/biobetters-market.asp
CAR T-Cell Therapy Market@ https://www.persistencemarketresearch.com/market-research/car-t-cell-therapy-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on "micros" by Persistence Market Research helps companies overcome their "macro" business challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Clostridium Difficile Infection Treatment Market to Get Digitally Distilled here
News-ID: 2556338 • Views: …
More Releases from Persistence Market Research
Electrical Enclosures Market to Reach US$ 12,711.6 Million by 2032 Driven by Ris …
The global electrical enclosures market is experiencing significant momentum, supported by rising demand for reliable equipment protection, enhanced workplace safety, and rapid industrial automation across multiple sectors. According to the latest study by Persistence Market Research, global electrical enclosures sales revenue is projected to reach US$ 8,163.9 million in 2025, and continue expanding at a CAGR of 6.5% from 2025 to 2032, ultimately reaching US$ 12,711.6 million by 2032. With…
Flooring and Carpets Market Set to Expand at 5.4% CAGR Through 2030, Reports Per …
The global flooring and carpets market continues to demonstrate robust expansion as demand accelerates across residential, commercial, and industrial sectors. The market is forecast to grow steadily at a CAGR of 5.4% between 2023 and 2030, increasing from US$303.2 Bn in 2023 to an estimated value of US$438.2 Bn by 2030. This growth trajectory reflects a combination of macroeconomic infrastructure investments, growing construction activities, and rising urbanization rates that are…
Croscarmellose Sodium (CCS) Market Expected to Reach US$ 487.0 Mn by 2032 Driven …
The global croscarmellose sodium (CCS) market is experiencing remarkable momentum as industries increasingly adopt CCS for its superior disintegration and absorption properties across pharmaceutical, nutraceutical, food, and cosmetic applications. According to the latest study by Persistence Market Research, the market is projected to rise from US$ 288.7 Mn in 2025 to US$ 487.0 Mn by 2032, expanding at an impressive CAGR of 7.8% during the forecast period. This growth highlights…
Earthmoving Equipment Market Valued to Hit US$ 87.7 Billion by 2031, Says Persis …
The global Earthmoving Equipment Market continues to demonstrate sustained growth, driven by large-scale construction activities, infrastructure development programs, housing investments, mining expansion, and technological modernization across heavy machinery fleets. Earthmoving equipment plays a critical role in large construction projects by enabling efficient soil excavation, land grading, foundation preparation, and material handling. These machines are widely utilized across road building, commercial construction, mining, forestry, agriculture, and urban development projects, supporting global…
More Releases for Clostridium
Veterinary Clostridium Vaccine Market
The veterinary clostridium vaccine market plays a crucial role in the prevention of clostridial diseases in livestock and companion animals. Clostridial infections, caused by bacteria from the Clostridium genus, can lead to severe health issues and significant economic losses in the agriculture sector. Vaccination is one of the most effective methods to control these infections, which include conditions like enterotoxemia, tetanus, and gas gangrene. The growing awareness of animal health,…
Clostridium Diagnostics Market Analysis, Size, Share & Trends | 2031
In recent years, the global Clostridium Diagnostics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Clostridium Diagnostics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Clostridium Diagnostics Market to Witness Astonishing Growth by 2030
Clostridium Diagnostics market is projected to grow at a CAGR of 7.5% from 2024 to 2030. The growth in this market can be attributed to the increasing incidence of Clostridium-related diseases, rising demand for accurate and rapid diagnosis, and growing awareness about Clostridial infections. Important changes in the business allow key players to attain larger profits. This Clostridium Diagnostics Market study report is the best way to make changes with…
Clostridium Diagnostics Market - Empowering Precision, Defeating Infection: Adva …
Newark, New Castle, USA - new report, titled Clostridium Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Clostridium Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Clostridium Diagnostics market. The report offers an overview of the market, which…
Clostridium Vaccine Market Size, Price, Share | Forecast to 2027
Latest Updated Report 2023, The Global Clostridium Vaccine Market to Growing A CAGR of % during forecast period of 2023-2027. The Market is segmented by Global Clostridium Vaccine Market Breakdown by Application (Veterinary Clinic, Veterinary Hospital) by Type (General Type) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Clostridium Vaccine Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It…
Global Clostridium Difficile Immunoassays Market - Opportunities & Forecasts, 20 …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global clostridium difficile immunoassays market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able…
